CELU: celularity.com Kompaniya qiymatining sof foydaga nisbati
GURU.Markets platformasida Celularity Inc. (CELU) aksiyalarining narx dinamikasi -0.50 darajasida qayd etilgan. Celularity Inc. biomateriallarni sinovdan o'tkazishning yuqori xarajatlari tufayli potentsial likvidlik tanqisligiga duch kelmoqda. Biznes kengaytiriladigan, yuqori hosildorlikka ega hujayra mahsulotlarini ishlab chiqishga tayanadi. Qarish va onkologiyaga qarshi kurashishni maqsad qilgan yetakchi biologiya mutaxassislari loyihaning muvaffaqiyatini ta'minlamoqda.
%20P%2FE%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwa76aez.ocr-7cpmfb4&start=20220704&end=20261110&filename=GURU_Markets_-_CELU_-_Celularity-Inc._-_PE-Multiple "CELU: Celularity Corp Biznesning o‘zini qoplash muddati 04.07.2022 - 10.11.2026 | 👁️GURU.Markets👁️")
Celularity Inc (CELU) kompaniyasining tahliliy kesimlari
- narx va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi haqida ma'lumot:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Umumiy qarzning xususiy kapitalga nisbati Celularity Inc.|CELU - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati Celularity Corp|CELU - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Celularity Inc.|CELU - Kompaniyaning uzoq muddatli qarzlari|Qisqa muddatli qarz Celularity|Tezkor likvidlik ko‘rsatkichi celularity.com
- foyda va bozor multiplikatorlari tafsilotlari:
CELU - Sof foyda|Kutilayotgan sof foyda Celularity Inc.|CELU - Narxning foydaga nisbati|Kelajakdagi narxning foydaga nisbati Celularity Corp|CELU - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori Celularity Inc.|CELU - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda Celularity|CELU - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi celularity.com|CELU - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yilda bir aksiya uchun foydaning kutilayotgan dinamikasi Celularity Inc.
Kompaniyaning har tomonlama tahlili:celularity.com CELU
P/E koeffitsiyenti biznesning bozor qiymatini uning yillik sof foydasi bilan nisbatda aks ettiradi va joriy daromad tendentsiyalariga asoslangan investitsiyalarning qoplanish muddatini o'lchaydi. Moliyaviy hisobotlarning P/E tahlili donor mosligiga ehtiyoj sezmasdan universal immunoterapiya dori vositalarini yaratish uchun Celularity Inc. (CELU) ning xususiy stam hujayra texnologiyasini kengaytirishga oid bozor kutuvlarini baholash imkonini beradi.
Muhim raqobatchilar
P/E multiplikatori argenx.com|Narx-foyda koeffitsiyenti BNTX (BioNTech)|ABVX (ABIVAX) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori ADMA (ADMA Bio)|Biznesning o‘zini qoplash muddati Protagonist Corp (PTGX)|IMVT - Narxning foydaga nisbati|kiniksa.com (KNSA) - Narx-foyda koeffitsiyenti|Grifols (GRFS) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti Adaptive Biotech|Narx-foyda koeffitsiyenti CLDX|P/E multiplikatori Aurinia Corp|Narxning foydaga nisbati BioCryst (BCRX)|veratx.com - Narx-foyda multiplikatori|P/E multiplikatori DNTH (Dianthus Therapeutics, Inc.)|Pharvaris NV (PHVS) - Kapitalizatsiyaning foydaga nisbati|AbCellera Bio - P/E multiplikatori|Tourmaline (TRML) - Narx-foyda koeffitsiyenti|PGEN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati pharming.com (PHAR)|Narxning foydaga nisbati Nektar Therapeutics Inc.|Narxning foydaga nisbati UPB|Narx-foyda koeffitsiyenti ZBIO (Zenas Biopharma, Inc.)|P/E multiplikatori Immunome Bio (IMNM)|Narxning foydaga nisbati Gossamer Bio, Inc. GOSS|kalvista.com - Narxning foydaga nisbati|Septerna - P/E multiplikatori|PVLA - P/E multiplikatori|Savara Corp (SVRA) - Narxning foydaga nisbati|Rigel Corp - Kompaniya qiymatining sof foydaga nisbati|ANAB (AnaptysBio, Inc.) - P/E multiplikatori|astriatx.com (ATXS) - Biznesning o‘zini qoplash muddati|Narx-foyda koeffitsiyenti ENGN (enGene)|Bozor narxining sof foydaga nisbati RAPT|Aerovate Therapeutics - Narx-foyda koeffitsiyenti|Aclaris Therapeutics, Inc (ACRS) - Kapitalizatsiyaning foydaga nisbati|KYTX: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati TLSA (tizianalifesciences.com)|CABA: P/E multiplikatori|VTYX - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Theratechnologies Inc|Narx-foyda multiplikatori AVTX (Avalo Therapeutics Inc)|P/E multiplikatori ELDN|Narx-foyda koeffitsiyenti agenusbio.com AGEN|Climb Bio - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Zura Bio Ltd (ZURA)|aTyr - P/E multiplikatori|Adagene (ADAG) - Narx-foyda koeffitsiyenti|IMA: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Shattuck Labs (STTK)|Narxning foydaga nisbati Equillium Inc|Narxning foydaga nisbati CNTB|Narx-foyda koeffitsiyenti IMUX (Immunic, Inc.)|P/E multiplikatori atarabio.com (ATRA)|Narxning foydaga nisbati InflaRx IFRX|XFOR (x4pharma.com) - Kapitalizatsiyaning sof foydaga nisbati|Adicet - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati INMB (INmune Bio Inc)|BRNS: P/E multiplikatori|Kezar Life Sciences Inc (KZR) - P/E multiplikatori|Narxning foydaga nisbati SAB Biotherapeutics|AKTX: Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Enlivex Therapeutics (ENLV)|Narx-foyda koeffitsiyenti q32bio.com QTTB|P/E multiplikatori GOVX (GeoVax Labs Inc)|P/E multiplikatori Edesa Biotech Corp EDSA|IBIO: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati CARM (Carisma Therapeutics)|XTLB: P/E multiplikatori|BOLT - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati HCW Biologics, Inc.|Narx-foyda koeffitsiyenti Aptevo (APVO)|Narxning foydaga nisbati AIM ImmunoTech Inc. (AIM)|Narx-foyda koeffitsiyenti aditxt.com ADTX|GRI Bio - Narx-foyda koeffitsiyenti|P/E multiplikatori XORTX Therapeutics Inc XRTX|HIND - Narxning foydaga nisbati|REVB (Revelation Biosciences Corp) - Narx-foyda multiplikatori|INDP: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati scinai.com (SCNI)|CALI (CalciMedica Inc) - P/E multiplikatori|Narx-foyda koeffitsiyenti Affimed Therapeutics (AFMD)|P/E multiplikatori ALLK|HOOK - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati IGM Biosciences IGMS|iteostherapeutics.com - Narxning foydaga nisbati|OCEA: Narx-foyda koeffitsiyenti|TCBP - P/E multiplikatori|Third Harmonic Bio, Inc (THRD) - Narxning foydaga nisbati
